DrugPatentWatch Database Preview
Lupin Ltd Company Profile
» See Plans and Pricing
What is the competitive landscape for LUPIN LTD, and what generic alternatives to LUPIN LTD drugs are available?
LUPIN LTD has one hundred and forty-eight approved drugs.
There is one US patent protecting LUPIN LTD drugs. There are seventeen tentative approvals on LUPIN LTD drugs.
There are two patent family members on LUPIN LTD drugs in two countries and three hundred and twenty-seven supplementary protection certificates in sixteen countries.
Summary for Lupin Ltd
| International Patents: | 2 |
| US Patents: | 1 |
| Tradenames: | 126 |
| Ingredients: | 110 |
| NDAs: | 148 |
| Drug Master File Entries: | 194 |
| Patent Litigation for Lupin Ltd: | See patent lawsuits for Lupin Ltd |
| PTAB Cases with Lupin Ltd as petitioner: | See PTAB cases with Lupin Ltd as petitioner |
Drugs and US Patents for Lupin Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 078232-003 | Oct 6, 2010 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Lupin Ltd | FENOFIBRATE | fenofibrate | TABLET;ORAL | 204019-001 | Aug 17, 2015 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Lupin Ltd | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 206028-001 | Sep 28, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for LUPIN LTD drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Oral Suspension | 500 mg/5 mL | ➤ Subscribe | 2014-07-22 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
International Patents for Lupin Ltd Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Germany | 112007000920 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2007119249 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Lupin Ltd Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1506211 | PA2014026,C1506211 | Lithuania | Start Trial | PRODUCT NAME: DAPAGLIFLOZINUM + METFORMINUM; REGISTRATION NO/DATE: EU/1/13/900 20140116 |
| 0434450 | C990028 | Netherlands | Start Trial | PRODUCT NAME: ABACAVIR, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN/OF VAN EEN FARMACEUTISCH AANVAARDBAAR ESTER, IN HET BIJZONDER ABACAVIR SULFAAT; REGISTRATION NO/DATE: EU/1/99/112/001-002 19990708 |
| 0247633 | 97C0118 | France | Start Trial | PRODUCT NAME: ATORVASTATINE CALCIQUE TRIHYDRATE; REGISTRATION NO/DATE IN FRANCE: NL 21960 DU 19970321; REGISTRATION NO/DATE AT EEC: PL 00018/0240 DU 19961107 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
